Rankings
▼
Calendar
AXSM Q4 2018 Earnings — Axsome Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
AXSM
Axsome Therapeutics, Inc.
$8B
Q4 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$9M
Net Income
-$10M
EPS (Diluted)
$-0.32
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$10M
Free Cash Flow
-$10M
Stock-Based Comp.
$353,080
Balance Sheet
Total Assets
$15M
Total Liabilities
$14M
Stockholders' Equity
$937,921
Cash & Equivalents
$14M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$9M
-$6M
-46.7%
Net Income
-$10M
-$7M
-29.2%
← FY 2018
All Quarters
Q1 2019 →